According to the research report, the global biopharmaceuticalCMO and CRO market size is expected to touch USD 59.13 Billion by 2030, from USD 31.17 Billion in 2021, growing with a significant CAGR of 7.4% from 2022 to 2030.
The biopharmaceutical CMO and CRO report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global biopharmaceutical CMO and CRO in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global biopharmaceutical CMO and CRO market, which
aids companies operating in the market in making strategic development
decisions. The study also elaborates on significant changes that are highly
anticipated to configure growth of the global biopharmaceutical CMO and CRO during
the forecast period. It also includes a key indicator assessment that
highlights growth prospects of this market and estimates statistics related to
growth of the market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1289
| Report Highlights | Details |
| Market Size | USD 59.4 Billion by 2030 |
| Growth Rate | CAGR of 7.4% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Source, Service |
| Regional Scope | North America, APAC, Europe, Latin America, MEAN, Rest of the World |
This study covers a detailed segmentation
of the global biopharmaceutical CMO and CRO market, along with key information
and a competition outlook. The report mentions company profiles of players that
are currently dominating the global biopharmaceutical CMO and CRO market,
wherein various developments, expansions, and winning strategies practiced and
implemented by leading players have been presented in detail.
Key Players
- Lonza
- JRS Pharma
- Samsung Biologics
- CMC Biologics
- TOYOBO Co. Ltd.
- RentschlerBiotechnologie
- FUJIFILM Diosynth Biotechnologies
- WuXi Biologics
- Patheon
- BoehringerIngelheim
- PRA Health Sciences
- LabCorp
Market Segmentation
- Contract Manufacturing
- Process Development
- Upstream
- Downstream
- Fill & Finish Operations
- Analytical & QC studies
- Packaging
- Process Development
- Contract Research
- Inflammation & Immunology
- Cardiology
- Oncology
- Neuroscience
- Others
By Source
- Mammalian
- Non-Mammalian
By Product
- Biologics
- Vaccines
- Monoclonal antibodies (MABs)
- Recombinant Proteins
- Antisense, RNAi, & Molecular Therapy
- Others
- Biosimilars
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
The research methodology adopted by
analysts for compiling the global biopharmaceutical CMO and CRO report is based
on detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global biopharmaceutical CMO and CRO market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Source Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Biopharmaceutical CMO and CRO Market, By Product
7.1. Biopharmaceutical CMO and CRO Market, by Product Type, 2021-2030
7.1.1. Biologics (Vaccines, Monoclonal antibodies (MABs), Recombinant Proteins, Others)
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Biosimilars
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Biopharmaceutical CMO and CRO Market, By Service
8.1. Biopharmaceutical CMO and CRO Market, by Service, 2021-2030
8.1.1. Contract Manufacturing (Process Development, Fill & Finish Operations, Analytical & QC studies, Packaging)
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Contract Research (Inflammation & Immunology, Cardiology, Oncology, Neuroscience, Others)
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Biopharmaceutical CMO and CRO Market, By Source
9.1. Biopharmaceutical CMO and CRO Market, by Source, 2021-2030
9.1.1. Mammalian
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Non-Mammalian
9.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Biopharmaceutical CMO and CRO Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.2. Market Revenue and Forecast, by Service (2019-2030)
10.1.3. Market Revenue and Forecast, by Source (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Service (2019-2030)
10.1.4.3. Market Revenue and Forecast, by Source (2019-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.5.2. Market Revenue and Forecast, by Service (2019-2030)
10.1.5.3. Market Revenue and Forecast, by Source (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.2. Market Revenue and Forecast, by Service (2019-2030)
10.2.3. Market Revenue and Forecast, by Source (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Service (2019-2030)
10.2.4.3. Market Revenue and Forecast, by Source (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Service (2019-2030)
10.2.5.3. Market Revenue and Forecast, by Source (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Service (2019-2030)
10.2.6.3. Market Revenue and Forecast, by Source (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.7.2. Market Revenue and Forecast, by Service (2019-2030)
10.2.7.3. Market Revenue and Forecast, by Source (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.2. Market Revenue and Forecast, by Service (2019-2030)
10.3.3. Market Revenue and Forecast, by Source (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Service (2019-2030)
10.3.4.3. Market Revenue and Forecast, by Source (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Service (2019-2030)
10.3.5.3. Market Revenue and Forecast, by Source (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Service (2019-2030)
10.3.6.3. Market Revenue and Forecast, by Source (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.7.2. Market Revenue and Forecast, by Service (2019-2030)
10.3.7.3. Market Revenue and Forecast, by Source (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.2. Market Revenue and Forecast, by Service (2019-2030)
10.4.3. Market Revenue and Forecast, by Source (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Service (2019-2030)
10.4.4.3. Market Revenue and Forecast, by Source (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Service (2019-2030)
10.4.5.3. Market Revenue and Forecast, by Source (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Service (2019-2030)
10.4.6.3. Market Revenue and Forecast, by Source (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.7.2. Market Revenue and Forecast, by Service (2019-2030)
10.4.7.3. Market Revenue and Forecast, by Source (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.2. Market Revenue and Forecast, by Service (2019-2030)
10.5.3. Market Revenue and Forecast, by Source (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Service (2019-2030)
10.5.4.3. Market Revenue and Forecast, by Source (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.5.2. Market Revenue and Forecast, by Service (2019-2030)
10.5.5.3. Market Revenue and Forecast, by Source (2019-2030)
Chapter 11. Company Profiles
11.1. Lonza
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. JRS Pharma
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Samsung Biologics
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. CMC Biologics
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. TOYOBO Co. Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. RentschlerBiotechnologie
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. FUJIFILM Diosynth Biotechnologies
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. WuXi Biologics
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Patheon
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. BoehringerIngelheim
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. PRA Health Sciences
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. LabCorp
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments